| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 10533 |
| 1 | METHOTREXATE SODIUM | 8739 |
| 2 | INFLIXIMAB | 8117 |
| 3 | METHOTREXATE | 7899 |
| 4 | RISPERIDONE | 7303 |
| 5 | OMEPRAZOLE MAGNESIUM | 6752 |
| 6 | GABAPENTIN | 6536 |
| 7 | ASPIRIN | 6316 |
| 8 | ACETAMINOPHEN | 6098 |
| 9 | ONABOTULINUMTOXINA | 6067 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 1473 | 0.3807 |
| 1 | OSPEMIFENE | 200 | 0.2460 |
| 2 | VEDOLIZUMAB | 2161 | 0.2320 |
| 3 | BOTULINUM TOXIN TYPE A | 908 | 0.2132 |
| 4 | FOSCARNET SODIUM | 197 | 0.2096 |
| 5 | ARIPIPRAZOLE LAUROXIL | 150 | 0.2055 |
| 6 | GADOXETATE DISODIUM | 76 | 0.1969 |
| 7 | ISAVUCONAZONIUM SULFATE | 103 | 0.1907 |
| 8 | CEFTOLOZANE AND TAZOBACTAM | 106 | 0.1879 |
| 9 | BRIVARACETAM | 203 | 0.1840 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 2995 |
| 1 | Purine Antimetabolite [EPC] | 2373 |
| 2 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1254 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 698 |
| 4 | Tetracycline-class Drug [EPC] | 693 |
| 5 | Stimulant Laxative [EPC] | 222 |
| 6 | Antiarrhythmic [EPC] | 126 |
| 7 | Anti-coagulant [EPC] | 15 |
| 8 | Direct Thrombin Inhibitor [EPC] | 15 |
| 9 | GLP-2 Analog [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin B6 Analog [EPC] | 5 | 0.0641 |
| 1 | Purine Antimetabolite [EPC] | 2373 | 0.0545 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 698 | 0.0266 |
| 3 | Antiarrhythmic [EPC] | 126 | 0.0251 |
| 4 | Stimulant Laxative [EPC] | 222 | 0.0236 |
| 5 | Tetracycline-class Drug [EPC] | 693 | 0.0227 |
| 6 | GLP-2 Analog [EPC] | 14 | 0.0222 |
| 7 | Insulin Analog [EPC] | 2995 | 0.0172 |
| 8 | Leptin Analog [EPC] | 10 | 0.0172 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1254 | 0.0154 |